In contrast to triple-negative breast cancers, immune-enriched ER-positive breast cancers are characterized by a distinctive immune profile which is dominated by TGF-β signaling, dysfunctional CD8+ T cells, and enrichment of M2 tumor-associated macrophages [42]. The gene discussed is TGFB1; the disease is neoplasm.